Testicular-specific drug delivery

Drug – bio-affecting and body treating compositions – In vivo diagnosis or in vivo testing – Magnetic imaging agent

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

424258, 424263, 424264, 424266, 424267, 2602395, 2603974, 564381, 564382, 514 19, 514176, 514 11, 514311, 514356, 514277, 514357, 514492, A61K 4900, A61K 31455, A61K 3344, A61K 3147, C07J 100, C01G 4106, C07C 8728, C07D23902

Patent

active

046222189

ABSTRACT:
Testicularly acting drug species are site-specifically/sustainedly delivered to the testes by administering to a male in need of such treatment a pharmacologically effective amount of the target drug species [D] tethered to a reduced, blood-testis barrier penetrating lipoidal form [D--DHC] of a dihydropyridine.revreaction.pyridinium salt type redox carrier, e.g. 1,4-dihydrotrigonelline. Oxidation of the dihydropyridine carrier moiety in vivo to the ionic pyridinium salt type drug/carrier entity [D--QC].sup.+ prevents elimination thereof from the testes, while elimination from the general circulation is accelerated, resulting in significant and prolongedly sustained testicular-specific drug activity, whether ascribable to the cleavage of the [D--QC].sup.+ entity and sustained release of the drug [D] in the testes and/or to [D--QC].sup.+ itself.

REFERENCES:
patent: 4479932 (1984-10-01), Bodor
Bodor, N. et al. (including Richard Roller and Sally Selk) J. Pharm. Sci., V. 67, No. 5, May 78, pp. 685-687.
Bodor, N. et al. (including Hassan H. Farag) Science, V. 214, No. 4527, Dec. 1981, pp. 1370-1372.
Bodor, N. et al. (including Hassan H. Farag) J. Medicinal Chem., V. 26, Mar. 83, pp. 313-317.
Cowie et al. J. Phys., V. 171, p. 1976 (London) 1964.
Kurmano, M. Actal Physiol. Scand., V. 71, p. 125, 1967.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Testicular-specific drug delivery does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Testicular-specific drug delivery, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Testicular-specific drug delivery will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-376526

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.